Then US President Donald Trump had batted for HCQ but WHO had sabotaged the study about efficacy of HCQ.
A new study has found HCQ (Hydroxychloroquine) increases the survival rate of severely infected Covid-19 patients by 200%.
After the effectiveness of the HCQ was talked about in the very beginning of the pandemic, India has banned its export.
India manufactures more than 70 percent of the global HCQ. Indian pharmaceutical companies IPCA Laboratories, Zydus Cadila and Wallace Pharmaceuticals have major shares.
Then US President Donald Trump had dialled Prime Minister Narendra Modi for supply of HCQ.
A study published in the medical journal Lancet had said HCQ was not effective against SARS-COV-2, the virus that causes Covid-19.
In June last year, Lancet retracted that study as it was found to be fake and fabricated.
The study was conducted by St Barnabas Medical Center in New Jersey and the result was published on May 31.
HCQ, an antimalarial drug, is very commonly used for the treatment of autoimmune diseases.
The WHO has lost its credibility as it’s slowly emerging it was complicit with China in hiding information about the pandemic and wreaking havoc.
Download Organiser Mobile App:
Mobile App: https://play.google.com/store/apps/de...
Visit Us At:
Follow us on:
Background Music Credits: https://www.bensound.com
India's External Affairs Minister S Jaishankar met Israeli President Isaac Herzog and discussed changes in the geopolitical landscape. Expressing his happiness to meet Herzog, Jaishanakar said that he deeply appreciated the Israeli President's commitment to taking "our bilateral ties to the next level". "Delighted to call on President @Isaac_Herzog. Our conversation covered changes in the geopolitical landscape. Deeply appreciate his visible commitment t ...